Evidence map›Paper›PMID 38977990›Full record

ArticleJournal of translational medicine2024

Synergistic effect of FOXM1 and BCL-2 inhibition in a preclinical treatment study on multiple myeloma.

Vivian Zhou, Manya Yu, Jiaqi Fu, Siegfried Janz, Xing Cui

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vivian Zhou *Department of Medicine, Cancer Center-Froedtert Hospital, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
Manya Yu *Department of Medicine, Cancer Center-Froedtert Hospital, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
Jiaqi FuThe First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, 250001, Shandong Province, PRC, China.
Siegfried JanzDepartment of Medicine, Cancer Center-Froedtert Hospital, Medical College of Wisconsin, Milwaukee, WI, 53226, USA. sjanz@mcw.edu.
Xing CuiDepartment of Oncology and Hematology, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250001, Shandong Province, PRC, China. cdz45@foxmail.com.ORCID 0000-0002-8771-5898

Funding

National Natural Science Foundation of China 82074348National Natural Science Foundation of China 82274491Riney Family Multiple Myeloma Research Initiative Riney Family Multiple Myeloma Research InitiativeShandong Provincial Natural Science Foundation Innovation Development Joint Fund ZR2023LZL009William G. Schuett, Jr., Multiple Myeloma Research Endowment William G. Schuett, Jr., Multiple Myeloma Research Endowment
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug SynergismForkhead Box Protein M1Multiple MyelomaProto-Oncogene Proteins c-bcl-2ApoptosisCell Line, TumorHumansForkhead Box Protein M1FOXM1 protein, humanProto-Oncogene Proteins c-bcl-2

Identifiers

PMID38977990
PMCPMC11232139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.